Long-term safety and effectiveness of ritonavir (RTV), nelfinavir (NFV) and lopinavir/ritonavir (LPWr) in antiretroviral (ARV)-experienced HIV-1-infected children

被引：0
|
作者：
Rudin, Christoph
Burri, Marcus
Shen, Yang
Rode, Richard
Nadal, David
机构：
[1] Univ Basel, Childrens Hosp, Basel, Switzerland
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Univ Zurich, Childrens Hosp, Div Infect Dis, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and Virological Efficacy after Switch to Once-Daily Lopinavir-Ritonavir in Treatment-Experienced HIV-1-Infected Children
    Foissac, Frantz
    Urien, Saik
    Hirt, Deborah
    Frange, Pierre
    Chaix, Marie-Laure
    Treluyer, Jean-Marc
    Blanche, Stephane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (09) : 4320 - 4325
  • [22] Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
    Ortiz, Roberto
    DeJesus, Edwin
    Khanlou, Homayoon
    Voronin, Evgeniy
    van Lunzen, Jan
    Andrade-Villanueva, Jaime
    Fourie, Jan
    De Meyer, Sandra
    De Pauw, Martine
    Lefebvre, Eric
    Vangeneugden, Tony
    Spinosa-Guzman, Sabrina
    AIDS, 2008, 22 (12) : 1389 - 1397
  • [23] Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
    Andersson, Lars-Magnus
    Vesterbacka, Jan
    Blaxhult, Anders
    Flamholc, Leo
    Nilsson, Staffan
    Ormaasen, Vidar
    Sonnerborg, Anders
    Gisslen, Magnus
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (07) : 543 - 551
  • [24] Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis
    Crommentuyn, KML
    Mulder, JW
    Sparidans, RW
    Huitema, ADR
    Schellens, JHM
    Beijnen, JH
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (08) : E73 - E75
  • [25] Efficacy and safety of lopinavir/ritonavir-based antiretroviral therapy in HIV-1-infected subjects with advanced disease: a systematic review and meta-analysis
    van Wyk, Jean
    Fredrick, Linda M.
    Dorr, Pat
    Madihlaba, Tshepiso
    FUTURE VIROLOGY, 2015, 10 (08) : 949 - 959
  • [26] Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children:: a prospective cohort study
    Resino, S
    Bellón, JM
    Ramos, JT
    Gonzalez-Rivera, M
    de José, MI
    González, MI
    Gurbindo, D
    Mellado, MJ
    Cabrero, E
    Muñoz-Fernández, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (05) : 921 - 931
  • [27] Pharmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children
    la Porte, Charles
    van Heeswijk, Rolf
    Mitchell, Charles D.
    Zhang, Guijun
    Parker, Jackie
    Rongkavilit, Chokechai
    ANTIVIRAL THERAPY, 2009, 14 (04) : 603 - 606
  • [28] Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy
    Chadwick, Ellen G.
    Yogev, Ram
    Alvero, Carmelita G.
    Hughes, Michael D.
    Hazra, Rohan
    Pinto, Jorge A.
    Robbins, Brian L.
    Heckman, Barbara E.
    Palumbo, Paul E.
    Capparelli, Edmund V.
    AIDS, 2011, 25 (05) : 643 - 649
  • [29] Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1-Infected Subjects at 48 Weeks
    Zajdenverg, Roberto
    Podsadecki, Thomas J.
    Badal-Faesen, Sharlaa
    Andrade-Villanueva, Jaime
    Gathe, Joseph
    Mingrone, Horacio
    Fredrick, Linda M.
    Gaultier, Isabelle A.
    Woodward, W. Chris
    Bernstein, Barry M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (02) : 143 - 151
  • [30] Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients
    Campo, RE
    Lalanne, R
    Tanner, TJ
    Jayaweera, DT
    Rodriguez, AE
    Fontaine, L
    Kolber, MA
    AIDS, 2005, 19 (04) : 447 - 449
12345